Budget Amount *help |
¥17,550,000 (Direct Cost: ¥13,500,000、Indirect Cost: ¥4,050,000)
Fiscal Year 2011: ¥5,590,000 (Direct Cost: ¥4,300,000、Indirect Cost: ¥1,290,000)
Fiscal Year 2010: ¥5,590,000 (Direct Cost: ¥4,300,000、Indirect Cost: ¥1,290,000)
Fiscal Year 2009: ¥6,370,000 (Direct Cost: ¥4,900,000、Indirect Cost: ¥1,470,000)
|
Research Abstract |
We identified CD133 positive pancreatic cancer cells with high malignant potential. CD133 positive pancreatic cancer cells have strong invasive ability via SDF1-CXCR4 pathway. We also found that migration of CD105 positive pancreatic cancer cells was promoted by cancer-stromal interactions. Moreover, we clarified that collagen-internalization receptor CD280 was an important molecule for invasion of pancreatic cancer cells. We reduced the invasion of pancreatic cancer cells by knockdown of CD280. In the present study, we identified several molecules as promising therapeutic targets.
|